Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden (original) (raw)
Baeuerle PA, Baltimore D . (1988). I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science242: 540–546. ArticleCAS Google Scholar
Baldwin Jr AS . (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol14: 649–683. ArticleCAS Google Scholar
Basseres DS, Ebbs A, Levantini E, Baldwin AS . (2010). Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res70: 3537–3546. ArticleCAS Google Scholar
Baud V, Karin M . (2009). Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov8: 33–40. ArticleCAS Google Scholar
Biswas DK, Iglehart JD . (2006). Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J Cell Physiol209: 645–652. ArticleCAS Google Scholar
Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB et al. (2004). NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci USA101: 10137–10142. ArticleCAS Google Scholar
Bond M, Fabunmi RP, Baker AH, Newby AC . (1998). Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett435: 29–34. ArticleCAS Google Scholar
Brantley DM, Chen CL, Muraoka RS, Bushdid PB, Bradberry JL, Kittrell F et al. (2001). Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium. Mol Biol Cell12: 1445–1455. ArticleCAS Google Scholar
Cao Y, Karin M . (2003). NF-kappaB in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia8: 215–223. Article Google Scholar
Cao Y, Luo JL, Karin M . (2007). IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells. Proc Natl Acad Sci USA104: 15852–15857. ArticleCAS Google Scholar
Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, Park GY et al. (2007). Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol178: 6504–6513. ArticleCAS Google Scholar
Connelly L, Barham W, Pigg R, Saint-Jean L, Sherrill T, Cheng DS et al. (2010). Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. J Cell Physiol222: 73–81. ArticleCAS Google Scholar
Connelly L, Robinson-Benion C, Chont M, Saint-Jean L, Li H, Polosukhin VV et al. (2007). A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. J Biol Chem282: 10028–10035. ArticleCAS Google Scholar
Cude K, Wang Y, Choi HJ, Hsuan SL, Zhang H, Wang CY et al. (2007). Regulation of the G2-M cell cycle progression by the ERK5-NFkappaB signaling pathway. J Cell Biol177: 253–264. ArticleCAS Google Scholar
Everhart MB, Han W, Sherrill TP, Arutiunov M, Polosukhin VV, Burke JR et al. (2006). Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol176: 4995–5005. ArticleCAS Google Scholar
Fu M, Wang C, Li Z, Sakamaki T, Pestell RG . (2004). Minireview: cyclin D1: normal and abnormal functions. Endocrinology145: 5439–5447. ArticleCAS Google Scholar
Ghosh S, May MJ, Kopp EB . (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol16: 225–260. ArticleCAS Google Scholar
Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB et al. (2002). A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J16: 283–292. ArticleCAS Google Scholar
Han YP, Tuan TL, Wu H, Hughes M, Garner WL . (2001). TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci114: 131–139. CASPubMedPubMed Central Google Scholar
Hayden MS, Ghosh S . (2008). Shared principles in NF-kappaB signaling. Cell132: 344–362. ArticleCAS Google Scholar
Hennighausen L, Robinson GW . (2005). Information networks in the mammary gland. Nat Rev Mol Cell Biol6: 715–725. ArticleCAS Google Scholar
Jafri SH, Glass J, Shi R, Zhang S, Prince M, Kleiner-Hancock H . (2010). Thymoquinone and cisplatin as a therapeutic combination in lung cancer: in vitro and in vivo. J Exp Clin Cancer Res29: 87. Article Google Scholar
Karin M, Ben-Neriah Y . (2000). Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol18: 621–663. ArticleCAS Google Scholar
Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ et al. (2003). Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol163: 2113–2126. Article Google Scholar
Liu M, Ju X, Willmarth NE, Casimiro MC, Ojeifo J, Sakamaki T et al. (2009). Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo. Am J Pathol174: 1910–1920. ArticleCAS Google Scholar
Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C et al. (2009). Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature462: 104–107. ArticleCAS Google Scholar
Mistry P, Deacon K, Mistry S, Blank J, Patel R . (2004). NF-kappaB promotes survival during mitotic cell cycle arrest. J Biol Chem279: 1482–1490. ArticleCAS Google Scholar
Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, Sledge Jr GW . (1997). Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol Cell Biol17: 3629–3639. ArticleCAS Google Scholar
Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S et al. (2000). Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide. Oncogene19: 4159–4169. ArticleCAS Google Scholar
Pratt MA, Tibbo E, Robertson SJ, Jansson D, Hurst K, Perez-Iratxeta C et al. (2009). The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population. Oncogene28: 2710–2722. ArticleCAS Google Scholar
Roy PG, Thompson AM . (2006). Cyclin D1 and breast cancer. Breast15: 718–727. Article Google Scholar
Sethi G, Ahn KS, Aggarwal BB . (2008). Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis. Mol Cancer Res6: 1059–1070. ArticleCAS Google Scholar
Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD et al. (2007). Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Mol Cancer Ther6: 1973–1982. ArticleCAS Google Scholar
Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM et al. (1997). Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest100: 2952–2960. ArticleCAS Google Scholar
Tapia MA, Gonzalez-Navarrete I, Dalmases A, Bosch M, Rodriguez-Fanjul V, Rolfe M et al. (2007). Inhibition of the canonical IKK/NF kappa B pathway sensitizes human cancer cells to doxorubicin. Cell Cycle6: 2284–2292. ArticleCAS Google Scholar
Vallabhapurapu S, Karin M . (2009). Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol27: 693–733. ArticleCAS Google Scholar
Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV . (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature369: 669–671. ArticleCAS Google Scholar